Target intelligence / Profile preview

Golgi phosphoprotein 3-like (GOLPH3L)

Target
GOLPH3L
Molecular classification
Other (Golgi-localized phosphoprotein)
01

Overview

Golgi phosphoprotein 3-like (GOLPH3L) is a paralogue of Golgi phosphoprotein 3 (GOLPH3), found in vertebrate genomes. It binds to phosphatidylinositol 4-phosphate (PI4P), localizes to the Golgi apparatus in cells, and is required for efficient protein trafficking in secretory cells. Unlike GOLPH3, which interacts tightly with myosin 18A (MYO18A) and is an oncogene, GOLPH3L doesn't bind MYO18A and acts as an antagonist to GOLPH3, modulating Golgi morphology by promoting compaction when overexpressed and dispersal when depleted. Its expression is restricted to tissues with high secretory activity, such as salivary glands and small intestine, and it is thought to play a role in maintaining optimal secretion rates by counterbalancing GOLPH3's effects on the Golgi apparatus. GOLPH3L is not a receptor, enzyme, or transporter, but rather a regulatory phosphoprotein of the Golgi apparatus. Its functional role is to antagonize GOLPH3, affecting Golgi structure and trafficking, most evident in secretory tissues. There is currently no therapeutic or diagnostic application for GOLPH3L, nor is it directly implicated in disease.

Other names
Golgi phosphoprotein 3-likeGOLPH3LGPP34-related proteinGPP34R
02

Biological functions

Regulation of Golgi morphologyAnterograde trafficking (transport of proteins from the Golgi to other cell compartments)Inhibition of GOLPH3 functionMaintenance of secretory activity in cells
03

Disease associations

Other

Beyond the preview

Go deeper on Golgi phosphoprotein 3-like (GOLPH3L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golgi phosphoprotein 3-like (GOLPH3L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call